Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Nature Reviews. Cardiology|September 2, 2015
Dysfunctional HDL and atherosclerotic cardiovascular diseaseRobert S Rosenson, H Bryan Brewer, Benjamin J Ansell, et al.
Journal of the American College of Cardiology|November 14, 2015
Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With EvacetrapibStephen J Nicholls, Giacomo Ruotolo, H Bryan Brewer, et al.
Lancet (London, England)|June 7, 2015
Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trialG Kees Hovingh, John J P Kastelein, Sander J H van Deventer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 7, 2004
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesScott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
Molecular and Cellular Biology|March 23, 2002
Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol effluxTaro E Akiyama, Shuichi Sakai, Gilles Lambert, et al.
Clinical Chemistry|January 27, 2011
HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular eventsRobert S Rosenson, H Bryan Brewer, M John Chapman, et al.
Journal of the American College of Cardiology|September 11, 2004
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesScott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
Circulation|July 14, 2004
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesScott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
The Journal of Biological Chemistry|September 23, 2008
Asymmetry in the lipid affinity of bihelical amphipathic peptides. A structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptidesAmar A Sethi, John A Stonik, Fairwell Thomas, et al.
Journal of Lipid Research|March 3, 2005
Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cellsFlorent Lalanne, Gilles Lambert, Marcelo J A Amar, et al.
Pageof 20